Nijmegen
Netherlands
Radboud University Nijmegen - Radboud University Medical Center
1.Locally Advanced Rectal Cancer, 2.Bevacizumab, 3.Neoadjuvant chemoradiation, 4.Treatment failures, 5.Long term outcomes
Colorectal cancer, liver metastases, tumor response assessment, systemic treatment, RECIST1.1, total tumor volume, prognostic value
adjuvant chemotherapy, rectal cancer, real-world data, survival
1, Socioeconomic position2, Metastatic colorectal cancer3, Single-organ metastases4, Multi-organ metastases5, Screening6, Treatment 7, survival